Cargando…
TFE3 nuclear expression as a novel biomarker of ovarian sclerosing stromal tumors and associated with its histological morphology
Sclerosing stromal tumors of the ovary are benign and tend to occur in youthful women with lobular structures at low frequencies. Three types of cells, including luteinized cells, short spindle myoid cells, and intermediate cells, are found in the lobules which abundant in the blood vessels. Current...
Autores principales: | Zhao, Li, Yang, Zhongfeng, Zhou, Yan, Liu, Yuping, Luo, Qiuping, Jiang, Qingping, Wang, Hui, Wang, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394818/ https://www.ncbi.nlm.nih.gov/pubmed/37528481 http://dx.doi.org/10.1186/s13048-023-01241-y |
Ejemplares similares
-
TFE3 is a Novel Biomarker of Ovarian Sclerosing Stromal Tumours
por: Zhao, Li, et al.
Publicado: (2023) -
Bilateral Sclerosing Stromal Ovarian Tumor in an Adolescent
por: Naidu, Anjani, et al.
Publicado: (2015) -
Imaging characteristics of ovarian sclerosing stromal tumor
por: Zhou, Zhifeng, et al.
Publicado: (2022) -
Sclerosing Stromal Tumor: A Rare Ovarian Neoplasm
por: Bairwa, Shilpa, et al.
Publicado: (2017) -
Sclerosing stromal tumor: a rare ovarian neoplasm
por: Kadiroğulları, Pınar, et al.
Publicado: (2022)